Study on different doses of additive in regional anaesthesia for post operative pain relief
Not Applicable
Completed
- Conditions
- Health Condition 1: N719- Inflammatory disease of uterus, unspecified
- Registration Number
- CTRI/2019/04/018790
- Lead Sponsor
- AIIMS RAIPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
1)Patients willing to participate in the study and providing informed consent.
2)Age â?? >18 to <60 years.
3)ASA - I and II
4)Surgery â?? lower abdominal surgeries
Exclusion Criteria
1)Refusal to consent.
2)Allergy to local anaesthetics.
3)Skin Infection at the site of block.
4)BMI >30.
5)Pre-existing neuropathy involving lower limb.
6)Inability to comprehend VAS pain assessment score.
7)ASA III and ASA IV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method comparison of pain control in TAP block with ropivacaine alone and ropivacaine with 2 doses of dexamethasone.Timepoint: comparison of pain control in TAP block with ropivacaine alone and ropivacaine with 2 doses of dexamethasone.
- Secondary Outcome Measures
Name Time Method ATimepoint: NA